PCOS and vitamin D: a clinical appraisal

Arch Gynecol Obstet. 2024 Mar;309(3):907-915. doi: 10.1007/s00404-023-07227-x. Epub 2023 Sep 25.

Abstract

Purpose: Polycystic ovary syndrome (PCOS) is the most common endocrine-reproductive disease linked not just to infertility but also to serious comorbidities. There is a reported association between low vitamin D levels and multiple health conditions including PCOS. This narrative review aims to analyze the role of vitamin D in PCOS development, use of the vitamin D in the treatment of PCOS, and the molecular basis of these observations.

Methods: A Medline and PubMed research was performed, during the years 1990-2023, using a combination of keywords on such topic. According to the author's evaluation and target, papers were identified and included for a narrative review.

Results: There are associations between lower levels of vitamin D and PCOS, as well as with insulin resistance, metabolic syndrome, hyperandrogenemia, metabolic and endocrine disorders as well as the onset of oxidative stress and pro-inflammatory milieu, in PCOS women.

Conclusion: Vitamin D has a role in pathologic changes linked to PCOS. Molecular and clinical investigations which give new information about the role of vitamin D in the development of PCOS and related endocrine and metabolic disturbance are further needed.

Keywords: Endocrine disorders; Insulin resistance; Metabolic syndrome; PCOS; Vitamin D.

Publication types

  • Review

MeSH terms

  • Cross-Sectional Studies
  • Female
  • Humans
  • Insulin Resistance*
  • Multimorbidity
  • Polycystic Ovary Syndrome* / drug therapy
  • Vitamin D
  • Vitamins

Substances

  • Vitamin D
  • Vitamins